"I think there are no mistakes; we end up exactly where we are meant to, but, the only difference is that some people question everything and wake up, while others follow the society and continue to sleep. The end difference is between having the courage to see the TRUTH verses choosing to stay ignorant and conventional." -Somyata, Founder & Owner

Here is a list of my contribution in cancer research - 
​​
Writing Samples (Manuscripts) –

https://pdfs.semanticscholar.org/9df8/3cbff69a5b196dfe45cd322246ef667f53c4.pdf (Phase II - MRCC - Thal + IL-2 2009)
 
http://www.ncbi.nlm.nih.gov/pubmed/23622774 (PC - CTC 2013)
 
http://meetinglibrary.asco.org/content/89687-116 (MRCC - mTOR 2012))
 
http://www.ncbi.nlm.nih.gov/pubmed/22551785 (Phase II - MRCC - Sorafenib 2012)
 
http://www.ncbi.nlm.nih.gov/pubmed/23402284 (Phase II - CRPC - GM-CSF + K + M 2013)
 
http://www.ncbi.nlm.nih.gov/pubmed/19306412 (Phase II - MRCC - RAD001 2009)
 
http://www.ncbi.nlm.nih.gov/pubmed/19010868 (Phase II - MRCC - Trovax + IL-2 2008)
 
http://www.ncbi.nlm.nih.gov/pubmed/18525302 (Phase II - MRCC - Lenalidomide 2008)
 
http://www.ncbi.nlm.nih.gov/pubmed/18367115 (HRPC - Chemohormonal therapy 2009)
 
http://www.ncbi.nlm.nih.gov/pubmed/18528296 (Phase II - HRPC - Trovax+GM-CSF 2008)
 
http://www.ncbi.nlm.nih.gov/pubmed/18824432 (Pilot Study - HRPC - Rapamycin 2008)
 
http://www.ncbi.nlm.nih.gov/pubmed/19561532 (Phase II - MRCC -Trovax + IFN-a 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759205/ (Phase II - CRPC - Pomalidomide 2011)

https://journals.lww.com/amjclinicaloncology/Abstract/2008/12000/Bone_Targeted_Therapy__Phase_II_Study_of.2.aspx (Phase II - Strontium-89 2008)